Translations of NCCN Guidelines and NCCN Guidelines for Patients are available in Arabic.
Since 2015, the King Abdulaziz Medical City in collaboration with NCCN, established the MENA-NCCN Regional Center to enhance communication and facilitate dissemination of cancer-related information including modification of NCCN Guidelines to colleagues in the MENA region. Recently, Kanan Mamdouh Alshammari, MD, Department of Oncology, King Abdullah Specialized Children’s Hospital, Ministry of National Guard, in Riyadh, Saudi Arabia, was appointed as the Director of the MENA-NCCN Regional Coordinating Center.
In 2022, the MENA-NCCN Regional Coordinating Center will update the full library of NCCN Guidelines: Middle East & North Africa (MENA) Editions. Moreover, the multidisciplinary and multiregional panels will develop three new adapted NCCN Guidelines for the MENA region focused on Ovarian Cancer; Genetic/Familial High-Risk Assessment for Breast, Ovarian, and Pancreatic; and Palliative Care.
Robert W. Carlson, MD, Chief Executive Officer, NCCN, reflected upon the value of the regional adaptation process, “The ongoing collaboration between NCCN and MENA NCCN is an important example of how the exchange of scientific perspective from regional and international experts serves to improve the quality and effectiveness of cancer care globally. NCCN looks forward to continuing and expanding this effort.”
Visit the Middle East - North Africa National Comprehensive Cancer Network (MENA-NCCN) MENA Regional Center for NCCN Collaboration for more information.
Adult Cancer Pain Version 2.2022 (English)
B-Cell Lymphomas Version 5.2018 (English)
Breast Cancer Version 2.2023 (English)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Version 2.2023 (English)
Colon Cancer Version 2.2022 (English)
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Version 2.2022 (English)
Hairy Cell Leukemia Version 1.2023 (English)
Hepatobiliary Cancers Version 4.2018 (English)
Hodgkin Lymphoma Version 2.2022 (English)
Non-Small Cell Lung Cancer Version 3.2022 (English)
Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer Version 1.2022 (English)
Prostate Cancer Version 4.2022 (English)
T-Cell Lymphomas Version 2.2022 (English)
For general NCCN queries and domestic programs, please visit our main contact page. We welcome the opportunity to explore potential business collaborations with you.